2024 OFFICIAL PARTNERS
Wuxi Apptec
Expertise Partner
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable the pharmaceutical and healthcare industry around the world to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, and cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions.
Momentum Biotechnologies
Innovation Partner
Momentum Biotechnologies is a specialized CRO focused on providing mass spectrometry-based native detection technologies for lead discovery to biopharmaceutical clients. Formerly known as Pure Honey Technologies, proudly maintains its unwavering commitment to delivering the same high-quality MS-based services, supportive staff, adaptable study options, superior data quality, and rapid delivery of experimental results. We help clients identify leads for novel mechanisms of action such as protein degradation/molecular glues, protein-protein interaction disruption (ASMS), and irreversible binding (Covalent Screening).
X-Chem
Program Partner
X-Chem, Inc. is a leader in small molecule drug discovery services for pharmaceutical and biotech companies. As pioneers of DNA-encoded chemical library (DEL) technology, the company leverages its market-leading DEL platform and medicinal chemistry expertise to discover novel small molecule leads against challenging, high-value therapeutic targets. Integrated with X-Chem’s extensive chemistry and computational technologies, project teams can deliver clinical candidates with unmatched speed. X-Chem’s advanced proprietary artificial intelligence (AI) technology and computational sciences accelerate all steps in the process. X-Chem also provides libraries, reagents, and informatic tools to allow DEL operators to get the most of their DEL platform. X-Chem empowers its partners to effectively build drug pipelines from target to clinical candidate, enhanced with AI and extensive data packages.
